AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.10) per share. This is a 16.67 percent increase over losses of $(0.12) per share from the same period last year.
Truist Financial Charts A Recovery Path After 43% Stock Decline In 2023 Since Its February Peak: Analysis
After a challenging 2023, Truist Financial (NYSE:TFC) is implementing significant changes that could boost its stock performance. According to a…